Clinical use of hepatic carcinoma associated membrane protein antigen (HAg18-1) for detection of primary hepatocellular carcinoma

Table 1 The results of HAg18-1 Eenzyme linked immunosorbent assays and alpha-fetoprotein radioimmunoassays

Disease	No. of cases	No. of positive cases		Positive rate (%)
		HAg18-1	AFP	HAg18-1	AFP
PHCC	100	81	68	81	68
HBC	5	1	2	20	40
MHC	10	1	2	10	20
HB	20	2	4	10	20
LC	20	2	4	10	20
GI malignant tumor	20	2	3	10	15
GI inflammatory diseases	20	1	2	5	10
Bank blood1	20	0	0	0	0

¹Controls